Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.67M | 1.95M | 4.06M | 4.40M | 4.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.67M | 1.95M | 4.06M | 4.40M | 4.26M |
| Cost of Revenue | 863.00K | 961.00K | 1.76M | 1.98M | 1.91M |
| Gross Profit | 807.00K | 988.00K | 2.30M | 2.42M | 2.35M |
| SG&A Expenses | 18.73M | 18.05M | 16.98M | 16.12M | 15.80M |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 22.00K | 44.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.91M | 48.11M | 45.81M | 30.45M | 29.01M |
| Operating Income | -47.10M | -45.02M | -40.61M | -26.05M | -24.76M |
| Income Before Tax | -49.36M | -47.84M | -50.22M | -60.78M | -63.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.36 | -47.84 | -50.22 | -60.78 | -63.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.36M | -47.84M | -50.22M | -60.78M | -63.42M |
| EBIT | -47.10M | -45.02M | -40.61M | -26.05M | -24.76M |
| EBITDA | -44.10M | -42.12M | -37.85M | -23.85M | -22.80M |
| EPS Basic | -1.49 | -1.48 | -1.62 | -2.83 | -3.48 |
| Normalized Basic EPS | -0.67 | -0.65 | -0.61 | -0.61 | -0.76 |
| EPS Diluted | -1.49 | -1.48 | -1.62 | -2.83 | -3.48 |
| Normalized Diluted EPS | -0.67 | -0.65 | -0.61 | -0.61 | -0.76 |
| Average Basic Shares Outstanding | 135.37M | 130.64M | 121.82M | 107.13M | 88.81M |
| Average Diluted Shares Outstanding | 135.37M | 130.64M | 121.82M | 107.13M | 88.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |